Development of an improved DTP vaccine and DTP-based combination vaccines

The first Regional Meeting on Improved DPT Vaccine and DTP-based Combination Vaccines, Washington, D.C., Sept. 1993, organized by SIREVA of PAHO in cooperation with the Children's Vaccine Initiative, formulated, inter alia, the following recommendation: "support research and development leading to the production of improved, new and combined vaccines in conjunction with the CVI and other related programs. A Program of Consortia for Research and Development for new DTP vaccines was designed to implement this recommendation. This Consortia will be multidisciplinary and made up of scientists and technicians in various institutions in different countries. They will cover all aspects of basic, directed and applied research in the development, production and quality control of the new vaccines. The active participation in research and technical cooperation among different institutions, public or private, from different countries of the Region, will enable the Region itself to take part in the development of new immunizing agents. This Master Plan will serve as the basis for the design, organization and implementation of the project

Estudio, diseno e implementacion de una politica nacional de médicamentos esenciales: Colombia / Study, design and implementation of the national essential drugs policy: Colombia

El presente documento es un resumen del informe final y se compone de dos partes: 1. Una presentacion de los terminos de referencia y de la situación global del sector farmaceutico en Colombia. 2. Un resumen de las principales recomendaciones del informe de acuerdo a los terminos de referencia (puntos 1 al 7). El punto 8, "Plan de acción", elaborado con los responsables del Ministerio de Salud, traduce las diferentes recomendaciones del informe, en las lineas generales de un plan de acción nacional de médicamentos esenciales, a largo plazo